Top Tweets for #LIPFENDRA
Statin intolerant. On ezetimibe LDL-C dropped from 213 to 102. Cardio “you must target <50!”🤨 Says I should try a new LDL lowering drug called #Lipfendra, an "oral PSCk9i that is *PROVEN* to lower LDL!" Whether it reduces ASCVD is unknown. NO!🤬 FFS what has medicine become?
The @US_FDA has approved #Lipfendra (#enlicitide), an oral PCSK9 inhibitor, expanding treatment options for adults with #hypercholesterolemia who require #LDL-C lowering.
https://t.co/FNB8y6MgPI
@Merck
सुई हान्ने झन्झटबाट मुक्ति! खराब कोलेस्ट्रोल घटाउने पहिलो खाने चक्की 'लिपफेन्ड्रा'लाई एफडीए को स्वीकृति। क्लिनिकल परीक्षणमा यसले ५९% सम्म कोलेस्ट्रोल घटाएको छ। पूरा समाचार पढ्नुहोस 👇
#Cholesterol #FDAApproval #Lipfendra #HeartHealth #CardiovascularHealth
https://t.co/2jgCk8LI70
స్టాటిన్ పడదా? ఇంజెక్షన్ వద్దా? కొత్త కొలెస్ట్రాల్ టాబ్లెట్ వచ్చింది! | Dr M S S Mukharjee
#Lipfendra #Enlicitide #PCSK9 #Cholesterol #LDL #HeartHealth #Statin #Cardiology #drmssmukharjee Dr M S S Mukharjee is a Senior Interventional Cardiologist and Managing Director of Pulse Heart Super Speciality Hospital, Miyapur, Hyderabad. Through this channel, he shares clear, evidence-based health information to help people understand their bodies, prevent disease, and make better health decisions. You will find videos on heart health, cholesterol, blood pressure, diabetes, lifestyle, prevention, medical myths, new research explained in simple language, and practical advice for everyday life. Complex medical topics are broken down so that anyone can understand and apply them. This channel is built on a simple belief: informed patients live longer and healthier lives. Whether you are a patient, a caregiver, a medical student, or someone who wants to stay healthy, this space is for you.
#EstadosUnidos aprobó #Lipfendra, una pastilla para combatir el #colesterol malo. Ayuda a bajar los niveles de grasa que circula en la sangre sin inyecciones y cuida la salud del corazón. @US_FDA @WHO
https://t.co/mj8eL6mAbb
Lipfendra: cómo funciona el nuevo tratamiento aprobado para reducir el colesterol “malo”
#elCaribe #elCariberd #lipfendra #colesterol
https://t.co/yAzv1TJaJG
Now got #FDA approved. 😊😍
#Lipfendra (#enlicitide), oral PCSK9 inhibitor.
Very good news for those with resistant hypercholesterolemia who don’t like injections. 😁💉
In the phase 3 CORALreef Lipids trial, the oral PCSK9 inhibitor enlicitide reduced LDL cholesterol by 57% at 24 weeks and also lowered non-HDL cholesterol, apolipoprotein B, and lipoprotein(a). Adverse events were similar in the two groups. Full trial results: https://t.co/o5RS02KCWi
Editorial: Exploring a New “Reef” in Dyslipidemic Risk Reduction https://t.co/W3KfZHkxMD
A once-daily oral therapy, #Lipfendra offers a new approach to #PCSK9-targeted treatment beyond injectable options.
#DrugDiscovery #CardiovascularResearch #Biotechnology
💊FDA Approval Update | #Lipfendra (enlicitide)
A new milestone in cholesterol management! 🧬
The #FDA has approved Lipfendra, the first oral #PCSK9 inhibitor, to lower #LDL-C in adults with hypercholesterolemia or heterozygous familial hypercholesterolemia (HeFH).
🔬By blocking PCSK9, Lipfendra enhances LDL receptor activity and promotes LDL-C clearance.
📊 In Phase 3 trials (n=3,207), Lipfendra reduced LDL-C by:
⬇️ 56% in high cardiovascular risk patients
⬇️ 59% in HeFH patients
A once-daily oral therapy, Lipfendra offers a new approach to PCSK9-targeted treatment beyond injectable options.
https://t.co/9DqeB9WyEd
#DrugDiscovery #CardiovascularResearch #Biotechnology
💊FDA Approval Update | #Lipfendra (enlicitide)
A new milestone in cholesterol management! 🧬
The #FDA has approved Lipfendra, the first oral #PCSK9 inhibitor, to lower #LDL-C in adults with hypercholesterolemia or heterozygous familial hypercholesterolemia (HeFH).
🔬By blocking PCSK9, Lipfendra enhances LDL receptor activity and promotes LDL-C clearance.
📊 In Phase 3 trials (n=3,207), Lipfendra reduced LDL-C by:
⬇️ 56% in high cardiovascular risk patients
⬇️ 59% in HeFH patients
A once-daily oral therapy, Lipfendra offers a new approach to PCSK9-targeted treatment beyond injectable options.
https://t.co/9DqeB9WyEd
#DrugDiscovery #CardiovascularResearch #Biotechnology
Merck’s #Lipfendra (#enlicitide) now the first #oral #PCSK9i, for adults w/ #hypercholesterolemia (incl. #HeFH). Ph3: 56–59% #LDL-C reduction vs PCB @ 24 wks. PO alternative to injectable PCSK9s, though dosing requires 8hr #fasting + 30 min post-dose fasting. #CVOT ongoing.
Last Seen Hashtags on Sotwe
nolimit(*)
Seen from Ecuador
ALLHailDakAttack
Seen from United States
stw selingkuh
Seen from Indonesia
momsonn()()()() or #nolimits()()() +filter:native_video
เย็ดนักเรียน
Seen from Thailand
มีคลิปขาย
Seen from Thailand
teenageer #momsonn #omegle #nolimits
Seen from France
omegle()****************
Seen from United States
somali wasmo
Most Popular Users
Elon Musk 
@elonmusk
241.6M followers
Barack Obama
@barackobama
119M followers
Cristiano Ronaldo
@cristiano
114.1M followers
Donald J. Trump
@realdonaldtrump
111.8M followers
Narendra Modi
@narendramodi
107.2M followers
Rihanna
@rihanna
98.7M followers
NASA
@nasa
92.4M followers
Justin Bieber
@justinbieber
91.8M followers
KATY PERRY
@katyperry
89.8M followers
Taylor Swift
@taylorswift13
83.8M followers
Lady Gaga
@ladygaga
75.2M followers
Virat Kohli
@imvkohli
73M followers
Kim Kardashian
@kimkardashian
70.8M followers
YouTube
@youtube
68.8M followers
Neymar Jr
@neymarjr
66M followers
Bill Gates
@billgates
65M followers
Selena Gomez
@selenagomez
62.9M followers
The Ellen Show
@theellenshow
62.3M followers
CNN
@cnn
61.8M followers
X
@x
60.7M followers